Amazon is being suggested as a potential acquirer of Hims & Hers ($HIMS), a telehealth company, as interest in the stock appears to be growing. The suggestion follows the recent appointment of a former FDA deputy commissioner and a former Pfizer executive to Hims & Hers, indicating a strengthening of its leadership team. Additionally, MindMed ($MNMD) has appointed Gregg Pratt, Ph.D., as its Chief Regulatory and Quality Assurance Officer, marking a significant move in its management strategy. This follows a trend of notable executive changes in the biotech sector, including Jason Carter's hiring as chief legal officer at Vera ($VERA). The market is reacting positively to these developments, with some analysts highlighting the potential value of Hims & Hers stock in the current climate.
$MNMD nice hire yesterday Ah , EX $KRTX that got bought by $BMY He knows the sector! https://t.co/mxfOnWYgmF
BioCentury's latest roundup of management moves: Vera hired Jason Carter as chief legal officer. Plus: Gregg Pratt to lead regulatory and quality assurance at Mind Medicine, and an update from Medicus $VERA $MNMD $MDCX https://t.co/0YAB1dnMCd
$HIMS I think people are really seeing the value here and the gift adds Amazon created! A very nice Roth stock to own imo https://t.co/BQHxXdmWdy